Cargando…

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus

Detalles Bibliográficos
Autores principales:	Slotta-Huspenina, Julia, Drecoll, Enken, Feith, Marcus, Habermehl, Daniel, Combs, Stephanie E., Weichert, Wilko, Bettstetter, Marcus, Becker, Karen, Langer, Rupert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954453/ https://www.ncbi.nlm.nih.gov/pubmed/29769068 http://dx.doi.org/10.1186/s12967-018-1513-8

Ejemplares similares

MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2018)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2017)

Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
por: Jesinghaus, Moritz, et al.
Publicado: (2017)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2019)

Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas
por: Slotta-Huspenina, Julia, et al.
Publicado: (2012)

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2014)

A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas
por: Slotta-Huspenina, J, et al.
Publicado: (2013)

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
por: Straub, Melanie, et al.
Publicado: (2016)

Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma
por: Berg, Daniela, et al.
Publicado: (2011)

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2018)

A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2018)

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2019)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer
por: Dimpel, Rebekka, et al.
Publicado: (2022)

Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
por: Langer, Rupert, et al.
Publicado: (2008)

Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma
por: Jesinghaus, Moritz, et al.
Publicado: (2019)

Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer
por: Kohlruss, Meike, et al.
Publicado: (2021)

Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus
por: Fang, Hsin-Yu, et al.
Publicado: (2021)

Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics
por: Barroux, Melissa, et al.
Publicado: (2022)

Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations
por: Hiltner, Theresa, et al.
Publicado: (2023)

Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients
por: Hiltner, Theresa, et al.
Publicado: (2023)

Impact of HPV infection on oral squamous cell carcinoma
por: Götz, Carolin, et al.
Publicado: (2016)

Diverse ‘just-right’ levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer
por: Kohlruss, Meike, et al.
Publicado: (2021)

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
por: Aichler, Michaela, et al.
Publicado: (2014)

Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas
por: Berezowska, Sabina, et al.
Publicado: (2013)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
por: Heise, Joachim W, et al.
Publicado: (2001)

Squamous Cell Carcinoma of the Pancreas in a Patient with Germline BRCA2 Mutation-Response to Neoadjuvant Radiochemotherapy
por: Schultheis, Anne M., et al.
Publicado: (2014)

A microsatellite based multiplex PCR method for the detection of chromosomal instability in gastric cancer
por: Kohlruss, Meike, et al.
Publicado: (2018)

EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma
por: Bissinger, Oliver, et al.
Publicado: (2017)

Anastomotic leakage following resection of the esophagus—introduction of an endoscopic grading system
por: Bachmann, Jeannine, et al.
Publicado: (2022)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013)

A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients
por: Blank, Susanne, et al.
Publicado: (2014)

Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas – a single center experience
por: Peeken, Jan C., et al.
Publicado: (2019)

Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability
por: Kohlruss, Meike, et al.
Publicado: (2019)

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer
por: Malinowsky, K, et al.
Publicado: (2014)

Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
por: Summerer, Isolde, et al.
Publicado: (2015)

Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study
por: Bauer, Lukas, et al.
Publicado: (2015)

Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iuh83ou6atsp6p30fv7g02rlkp